We observed a delay in tumor appearance in all mice injected with FGFR1-deficient cells and these cells grew at a slower rate than FGFR1-competent cells regardless of treatment (Figure 9A–C), suggesting the FGFR1 signaling contributed to tumor cell growth in the mammary fatpad. The gene discussed is FGFR1; the disease is neoplasm.